Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.
Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback